about
Viral hemorrhagic fevers: advancing the level of treatmentHepatitis C: global epidemiology and strategies for control.Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries.Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection.Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysisMolecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome.Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device.Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007.Influenza A (H1N1) in Rome, Italy in family: three case reports.Measles Cases during Ebola Outbreak, West Africa, 2013-2106.Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser.High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: evidence from outbreak investigation.Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study.Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance studyEbola virus disease complicated with viral interstitial pneumonia: a case report.Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in ItalyDetection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient.Blood kinetics of Ebola virus in survivors and nonsurvivors.Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysisAre adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?Ebola: missed opportunities for Europe-Africa research.Short-term economic impact of the Zika virus outbreak.Zika virus and microcephaly: is the correlation causal or coincidental?The Middle East Respiratory Syndrome Coronavirus - A Continuing Risk to Global Health Security.Is hepatitis C virus eradication around the corner only 25 years after its discovery?Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach.Relationship between viremia and specific organ damage in Ebola patients: a cohort study.Hepatitis C virus treatment revolution: need for close monitoring.A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings.Measles outbreak on a cruise ship in the western Mediterranean, February 2014, preliminary report.Appropriateness of surgical antimicrobial prophylaxis in the Latium region of Italy, 2008: a multicenter study.Noninvasive positive-pressure ventilation.Healthcare-associated infection in Italy: annual point-prevalence surveys, 2002-2004.Authors reply: measles on the cruise ship: links with virus spreading into an emergency department in Southern Italy.Non-randomised Ebola trials--lessons for optimal outbreak research.The added value of long-lasting preparedness for the management of a patient with Ebola.Criteria for discharge of patients with Ebola virus diseases in high-income countries.
P50
Q21245298-B3782FD9-62D0-4E7C-9A96-64F5C5D861C3Q30248506-DE88885D-74E9-4725-A760-E63CA5A7E3B8Q30366119-7F9500E7-CE9C-49C1-8582-AEC16136C4C4Q30379449-48AE4009-4DD0-4577-95CD-A8B63A564C59Q30390940-3BCDB474-9C6B-497F-858A-F870735B57A4Q30500238-D4D0844F-7FA9-44E9-8DBA-EDF2970C13EAQ30988237-7CF21931-BB3D-4194-9773-897D94CD9379Q31050747-78C01BBD-4E37-40CB-97C0-20D5679B83E0Q33428314-23C9AB3A-A3A5-4DFC-9BBA-6867C5A71131Q33580378-E9CD1AC8-5846-445F-8E4A-497050631D01Q33724570-404FA4DC-8437-4721-9108-30E0CE8B844CQ33832119-22A88EA2-4AAF-45EC-AD48-F62884AEDCC6Q34133402-0EDCB38A-F135-452F-9504-CB82CF22A8B0Q34815753-B8654E22-FD15-429A-98A7-90570D890140Q35250361-E20899A8-49A8-4CBE-90A8-AFED88B67D14Q35809312-8DAC8D3A-1370-4A1D-AEFB-76FC8162054AQ35884983-C4320B8B-5012-4B91-8FF2-5F22F58AF4DFQ36240489-66CD70C6-7681-4611-AB0A-61EC85B17C8EQ36335941-6D4488B4-6A7C-498D-923B-A026B45D5E8FQ36775011-A5E64F6B-6EDA-44FA-BE09-A9515222F4B3Q37310771-130225F7-4176-41DE-9DCC-9D11D71AED4FQ37652490-8DC308D3-95C0-4AC7-982F-189C078E45B4Q38424462-5349BFFA-D626-4F60-9820-3487A7A7D485Q38858286-90F32CE0-F1E9-46ED-B1E9-1B9CFD538A7EQ39301401-9035AF9F-B369-4ADB-B1D5-75372E4410D5Q39753287-8D4CE894-DC6D-44FD-9631-AB86728E8965Q40410851-D02E1790-D67A-4B0A-AD0E-4175D56CCE8BQ41728669-0FAA17D5-EEA5-4667-A7B1-C9341491CEC0Q41757823-AC6B1179-981C-4E7C-A1EB-3DA85CE31F13Q41919010-AAD2EEC6-C6C1-427C-9EDD-AE629C3E556FQ42212594-8942F930-0C9D-4D6F-8ED6-A970397D156EQ42216496-51552BA1-DE95-4200-8A62-4CE3F49FCF3DQ42223013-9FBE32F7-9505-4D6A-8546-69F5E2BF8AD9Q42255380-1E1740D3-1EE3-4CA0-A672-66D4B8289EF1Q43046153-63856009-B22D-4C80-B484-CB6168B673D4Q43589102-91E41E21-67CD-44DB-B89E-5EC12CBB51DBQ43813666-DB9C4638-E3BB-4989-9152-5043CAC586B7Q43929126-76AE36A3-A98C-46F6-914D-25B63887B921Q44097348-219A1213-4D85-4099-BD5B-3E1156F01E66Q44100989-20E80C20-291F-499F-9DA3-47F5ABB74EBA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Simone Lanini
@ast
Simone Lanini
@en
Simone Lanini
@es
Simone Lanini
@nl
Simone Lanini
@sl
type
label
Simone Lanini
@ast
Simone Lanini
@en
Simone Lanini
@es
Simone Lanini
@nl
Simone Lanini
@sl
prefLabel
Simone Lanini
@ast
Simone Lanini
@en
Simone Lanini
@es
Simone Lanini
@nl
Simone Lanini
@sl
P1053
C-7523-2012
P106
P1153
24460488500
P21
P31
P3829
P496
0000-0002-6743-4001